Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 23
Phase 32

Trial Status

Terminated4

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT04277546Phase 2Terminated
Open-label Extension Study of Brazikumab in Ulcerative Colitis
Ulcerative Colitis
StudydirectorStart date: 2020-03-03
NCT03961815Phase 3Terminated
Open-label Extension Study of Brazikumab in Crohn's Disease
Crohn's DiseaseIBD
StudydirectorStart date: 2020-01-06

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

AstraZeneca

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT04277546Phase 2StudyDirector

Open-label Extension Study of Brazikumab in Ulcerative Colitis

Ulcerative Colitis
Terminated
NCT03961815Phase 3StudyDirector

Open-label Extension Study of Brazikumab in Crohn's Disease

Crohn's DiseaseIBD
Terminated
NCT03759288Phase 2/3StudyDirector

An Active and Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Crohn's Disease

Crohn's DiseaseIBD
Terminated
NCT03616821Phase 2StudyDirector

Placebo-Controlled Study of Brazikumab in Participants With Moderately to Severely Active Ulcerative Colitis

IBDUlcerative Colitis
Terminated

All 4 trials loaded